Assessment of the antiviral properties of recombinant surfactant protein D against influenza B virus in vitro

Virus Research

Volumn 195, Issue , 2015, Pages 43-46

  Hillaire, Marine L B ^a   van Eijk, Martin ^b   Vogelzang van Trierum, Stella E ^a   Nieuwkoop, Nella J ^a   van Riel, Debby ^a   Fouchier, Ron A M ^a   Kuiken, Thijs ^a   Osterhaus, Albert D M E ^a,c   Haagsman, Henk P ^b   Rimmelzwaan, Guus F ^a,c  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c Viroclinics Biosciences BV   (Netherlands)

Author keywords

Antiviral; Influenza; Surfactant protein D

Indexed keywords

ANTIVIRUS AGENT; LECTIN; RECOMBINANT PROTEIN; RECOMBINANT SURFACTANT PROTEIN D; SURFACTANT PROTEIN D; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; EPITHELIUM CELL; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLUENZA VIRUS A; INFLUENZA VIRUS B; MDCK CELL LINE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; TRACHEA MUCOSA; VIRUS NEUTRALIZATION; VIRUS STRAIN; ANIMAL; CELL CULTURE; DRUG EFFECTS; PHYSIOLOGY; PIG; SERODIAGNOSIS; VIROLOGY; VIRUS ATTACHMENT;

INFLUENZA A VIRUS; INFLUENZA B VIRUS; ORTHOMYXOVIRIDAE; SUS;

ANIMALS; ANTIVIRAL AGENTS; CELLS, CULTURED; EPITHELIAL CELLS; HUMANS; INFLUENZA B VIRUS; NEUTRALIZATION TESTS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; RECOMBINANT PROTEINS; SWINE; VIRUS ATTACHMENT;

EID: 84919359573     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2014.08.019     Document Type: Article

References (26)

1. Ambrose C.S., Levin M.J. The rationale for quadrivalent influenza vaccines. Hum. Vaccines Immunother. 2012, 8(1):81-88.
2. Belshe R.B. The need for quadrivalent vaccine against seasonal influenza. Vaccine 2010, 28(Suppl 4):D45-D53.
3. Camilloni B., Neri M., Lepri E., Iorio A.M. Cross-reactive antibodies in middle-aged and elderly volunteers after MF59-adjuvanted subunit trivalent influenza vaccine against B viruses of the B/Victoria or B/Yamagata lineages. Vaccine 2009, 27(31):4099-4103.
4. Chutinimitkul S., van Riel D., Munster V.J., van den Brand J.M., Rimmelzwaan G.F., Kuiken T., Osterhaus A.D., Fouchier R.A., de Wit E. In vitro assessment of attachment pattern and replication efficiency of H5N1 influenza A viruses with altered receptor specificity. J. Virol. 2010, 84(13):6825-6833.
5. FDA, 2012. FDA approves first quadrivalent vaccine to prevent seasonal influenza.
6. Hartshorn K., Chang D., Rust K., White M., Heuser J., Crouch E. Interactions of recombinant human pulmonary surfactant protein D and SP-D multimers with influenza A. Am. J. Physiol. 1996, 271(5 Pt 1):L753-L762.
7. Hatakeyama S., Sugaya N., Ito M., Yamazaki M., Ichikawa M., Kimura K., Kiso M., Shimizu H., Kawakami C., Koike K., Mitamura K., Kawaoka Y. Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors. J. Am. Med. Assoc. 2007, 297(13):1435-1442.
8. Hillaire M.L., Haagsman H.P., Osterhaus A.D., Rimmelzwaan G.F., van Eijk M. Pulmonary surfactant protein D in first-line innate defence against influenza A virus infections. J. Innate Immun. 2013, 5(3):197-208.
9. Hillaire M.L., van Eijk M., Nieuwkoop N.J., Vogelzang-van Trierum S.E., Fouchier R.A., Osterhaus A.D., Haagsman H.P., Rimmelzwaan G.F. The number and position of N-linked glycosylation sites in the hemagglutinin determine differential recognition of seasonal and 2009 pandemic H1N1 influenza virus by porcine surfactant protein D. Virus Res. 2012, 169(1):301-305.
10. Hillaire M.L., van Eijk M., van Trierum S.E., van Riel D., Saelens X., Romijn R.A., Hemrika W., Fouchier R.A., Kuiken T., Osterhaus A.D., Haagsman H.P., Rimmelzwaan G.F. Assessment of the antiviral properties of recombinant porcine SP-D against various influenza A viruses in vitro. PloS One 2011, 6(9):e25005.
11. Lin Y.P., Gregory V., Bennett M., Hay A. Recent changes among human influenza viruses. Virus Res. 2004, 103(1-2):47-52.
12. McCullers J., Saito T., Iverson A. Multiple genotypes of influenza B virus circulated between 1979 and 2003. J. Virol. 2004, 23:12817-12828.
13. Rimmelzwaan G.F., Baars M., Claas E.C., Osterhaus A.D. Comparison of RNA hybridization, hemagglutination assay, titration of infectious virus and immunofluorescence as methods for monitoring influenza virus replication in vitro. J. Virol. Methods 1998, 74(1):57-66.
14. Rota P.A., Hemphill M.L., Whistler T., Regnery H.L., Kendal A.P. Antigenic and genetic characterization of the haemagglutinins of recent cocirculating strains of influenza B virus. J. Gen. Virol. 1992, 73(Pt 10):2737-2742.
15. Shaw M.W., Xu X., Li Y., Normand S., Ueki R.T., Kunimoto G.Y., Hall H., Klimov A., Cox N.J., Subbarao K. Reappearance and global spread of variants of influenza B/Victoria/2/87 lineage viruses in the 2000-2001 and 2001-2002 seasons. Virology 2002, 303(1):1-8.
16. Stephenson I., Democratis J., Lackenby A., McNally T., Smith J., Pareek M., Ellis J., Bermingham A., Nicholson K., Zambon M. Neuraminidase inhibitor resistance after oseltamivir treatment of acute influenza A and B in children. Clin. Infect. Dis. 2009, 48(4):389-396.
17. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Cox N., Anderson L.J., Fukuda K. Mortality associated with influenza and respiratory syncytial virus in the United States. J. Am. Med. Assoc. 2003, 289(2):179-186.
18. Traynor K. First quadrivalent flu vaccine approved. Am. J. Health Syst. Pharm. 2012, 69(7):538.
19. van Eijk M., Rynkiewicz M.J., White M.R., Hartshorn K.L., Zou X., Schulten K., Luo D., Crouch E.C., Cafarella T.R., Head J.F., Haagsman H.P., Seaton B.A. A unique sugar-binding site mediates the distinct anti-influenza activity of pig surfactant protein D. J. Biol. Chem. 2012, 287(32):26666-26677.
20. van Eijk M., White M.R., Batenburg J.J., Vaandrager A.B., van Golde L.M., Haagsman H.P., Hartshorn K.L. Interactions of influenza A virus with sialic acids present on porcine surfactant protein D. Am. J. Respir. Cell Mol. Biol. 2004, 30(6):871-879.
21. van Eijk M., White M.R., Crouch E.C., Batenburg J.J., Vaandrager A.B., Van Golde L.M., Haagsman H.P., Hartshorn K.L. Porcine pulmonary collectins show distinct interactions with influenza A viruses: role of the N-linked oligosaccharides in the carbohydrate recognition domain. J. Immunol. 2003, 171(3):1431-1440.
22. van Riel D., Munster V.J., de Wit E., Rimmelzwaan G.F., Fouchier R.A., Osterhaus A.D., Kuiken T. H5N1 virus attachment to lower respiratory tract. Science 2006, 312(5772):399.
23. van Riel D., Munster V.J., de Wit E., Rimmelzwaan G.F., Fouchier R.A., Osterhaus A.D., Kuiken T. Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals. Am. J. Pathol. 2007, 171(4):1215-1223.
24. WHO, 2013. Update Number 178.
25. WHO, 2014a. Influenza Update.
26. WHO, 2014b. Influenza Update No. 211.